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The Future of Additive Manufacturing: Materialise's LBO – Exit Strategy & Returns
This investment paper reviews the potential Leveraged Buyout of Materialise, a service provider and software producer operating in the Additive
Manufacturing industry. An analysis of the company and market was conducted, facilitating the assessment of key market trends that enabled the
creation of investment strategies set to improve the company in various areas and aspects. The result of this work presented Materialise as an
attractive investment, with strong returns across a multitude of possible scenarios in the upcoming future.
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Executive Summary
Materialise is a solid target, yielding a MM of 7.0x and an IRR of 35% over a 6-year investment period    
Company Overview
Deal Rationale
Market Overview Exit Strategy & Returns
Materialise NV (NASDAQ: MTLS) is a global
provider of software tools, medical solutions and
sophisticated 3D printing services in the Additive
Manufacturing (AM) market.
Incorporated in 1990 and headquartered in Leuven,
Belgium, Materialise currently has over 2,000
employees and is present in over 20 countries.
The company is subdivided in three main
segments: Manufacturing, Software and Medical,
which combined offer products to over 8 different
industries, including: Automotive, Aerospace,








Pioneer in 3DP, global reach and disruptive tech.
Successful Acquisition History
6 acq. in the past decade with successful integration
Growing Market
7-Year CAGR estimates vary between 18% to
27%
Strong Financials
Increasing profitability and operating efficiency
Highly Skilled Workforce
3DP expertise both in management and engineering
The Additive Manufacturing market is divided into four
industries. Within this division, Materialise is both a
software vendor and a service provider. The
overall AM market is estimated to grow from $10.4bn








*source: EY Global 3DP survey 2019
Value Creation Plan Contingency Plan
Investment thesis relies on 3 strategies to derive
growth:
A. Organic Growth by increasing focus in the APAC
region through strategic partnerships, by
strengthening Materialise’s offer of metal-based
printing which a growing AM area and by expanding
the customer base in the Americas and Middle East.
B. Optimizing Operations by reducing SG&A and
R&D costs as a result of the synergies generated by
the strategic acquisition.
C. Strategic Acquisition of a Systems Manufacturer
to strengthen Materialise’s position in the AM
value chain. This vertical integration would allow
the company to become an all-in-one supplier.
Materialise’s transaction value (EV) is € 671M with an
entry multiple of 25.1x EBITDA. The deal will be
financed by 39% of Debt and 61% of Equity.
The exit will be performed in 2026, with a multiple of
12.1x. The Fund’s return is 7.0x MM and 35% IRR.
In case the Strategic Acquisition is not successful, a
standalone scenario of Materialise was performed with
a capital structure of 45% of debt and 55% Equity.
In this scenario, exit will occur in 2027, with a multiple of






















EV Net Debt Minority
Interests




Share of Companies by Industry
Exit Options & Due DiligenceExit & ReturnsValue Creation & Business PlanCompany & Market Overview
Company Overview | Company Profile & History
Innovation-driven, Materialise operates in 3 different segments within the Additive Manufacturing landscape
Company Profile Geographical Presence
▪ Materialise NV (NASDAQ: MTLS) is a global provider of
software tools, medical solutions and sophisticated 3D
printing services in the Additive Manufacturing market.
▪ One of the largest and most long-established independent
company in this sector, Materialise was incorporated on
the 28th of June 1990 under the Belgian company law.
▪ The company currently holds over 250 patents, including
160 specifically related to medical applications.
▪ Multinational company established through a combination
of organic growth and acquisitions.
▪ Materialise’s main subsidiaries include Engimplan,










Global presence in over 20 Countries
Company Description
Corporate Headquarters: Leuven, Belgian
Market Segments: Manufacturing; Software; Medical
Number of Employees: 2,177
Financial Highlights (2019)
Sales €196.7M (+ 6,5% vs. 2018)
Gross Profit €109.7M (+ 7,1% vs. 2018)
Net Profit €1.7M (- 43,0% vs. 2018)
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Company Overview | Business Model
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primarily by (i) the sale of





heavily affected by the
acquisition of ACTech,
boosting manufacturing’s
share of total revenue.
Manufacturing Segment
B2B service provider of 3D printing solutions through the co-
creation, prototyping and consultancy services with Materialise’s
engineers and designers, enabling the production of very complex parts
or products using various materials and technologies, on demand.
Software Segment
Provides the necessary sophisticated software tools to use additive
manufacturing to produce the highest standards’ products regardless of
complexity levels. It specializes in workflow software and is the
backbone of 3D printing. It also provides training and consulting
services for its products. It can also be sold as a standalone product.
Medical Segment
Provides customers with medical devices printed in-house such as
surgical guides and implants, licenses to medical software
packages and software maintenance contracts to ensure the level of
precision and accuracy required in Certified Medical Printing. Pioneering









Human resources are central to business
performance, with top-level engineers,
developers, designers and salespeople. The
industrial 3D printers and issued patents are







▪ Art & Fashion
▪ Healthcare
▪ Machinery














































▪ Freedom of Design
▪ Mass Customization
▪ Shortens time to Market








customers with support &
training services and even
a self-service component.
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Rapid Prototyping
▪ Prototypes are essential to verify the
product design with a model that matches
the real product, or to perform form, fit
and function tests, in order to meet the
customer’s requirements.
▪ Rapid Prototyping allows designers and
engineers to execute fast and frequent
revisions of their designs. Thanks to a
variety of available technologies and
materials, 3D-printed prototypes work for
both visual and functional testing.
1
Company Overview | Manufacturing Segment















▪ Printing of 3D products to industrial and
commercial customers.
▪ Co-creation: Materialise works together with
customers during the 3D printing process to solve
complex design challenges and to discuss how the
introduction of 3D printing can affect product
development, manufacturing workflow, business
models and customer experiences.
▪ i.materialise: Online service where customers can
buy 3D printed products or create their own and offer
them for sale to others through this platform.
2 Design and Engineering
▪ Services provided by highly specialized
designers and CAD engineers that
offer design and software support for
additive manufacturing, including
remodeling and file preparation, as
well as 3D scanning and measuring.
▪ These services are intended to add
value to the product design, ranging
from improved performance to
lowered cost.
3
The customer base for the





▪ Industrial machining art and design
▪ Consumer products
Customer Segments




▪ Complex product offerings are addressed
directly by specialized sales managers
▪ Straightforward products can be ordered directly
through the automated system “Materialise
OnSite”.
Sales and Marketing Ecosystem Partners
Revenue Model: The 3D Printing Process 
“Printing on demand in one of the world’s largest 3D printing factories while improving software solutions and acting as incubators 
for new verticals through the host of co-creations with industry leaders.” - Materialise Investor Presentation
Strategy
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Company Overview | Software Segment

















The customer base includes:
▪ 3D printing OEMs
▪ Manufacturers in other industries:
consumer goods, automotive,
aerospace, and hearing aid industries
▪ R&D departments
▪ Internal & External 3D printing service
offices.
Customer Segments
The distribution of the software is carried out by:
▪ OEM Partner Sales
▪ Direct Sales
▪ Third-Party Distributors
Local offices offer technical help before and after
the sale. OEMs and dealers often distribute
software products combined with 3D printers to
enhance the printers’ value proposition and
application.
Sales and Marketing Ecosystem Partners
“Offer proprietary software worldwide through programs and platforms that enable and enhance the functionality of 3D printers and
3DP operations” – Materialise Investor Presentation
Strategy
1. Sources of revenue in this segment are maintenance
contracts, software licenses, and hardware controller
sales along with custom software development services.
2. Licensing software products can be done perpetually or
on a time-basis, along with annual maintenance contracts
for software updates or support
Magics’ applications include:
▪ repairing and optimizing 3D models & analysing parts
▪ designing support structures
▪ making process-related design changes on STL1 files
▪ process planning & documenting customer projects
▪ nesting multiple parts in a single print run
Further offerings help complement the Magics’ Platform that provide
automation and other productivity improvements.
1) Magics Essentials: entry-level package offering premium data
preparation functionality which is used together with machine build
preparation software.
2) Magics Print: conglomerates the key build preparation tools and
straightforward build file generation technology (offered to machine
manufacturers as a product enhancement to their machines’ sale).
Upgrading to the expert Materialise Magics provides full data and build




▪ Build Processors and Machine Control Software 
▪ Materialise Controller
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Company Overview | Medical Segment

















The customer base for the Medical
Segment products and services
include:






The distribution of medical software is carried out by:
▪ Direct sales force
▪ Website
▪ PACS partners
The distribution of 3D printed medical devices is
executed through agreements with collaborative
partners. Clinical services may also be carried out by
Materialise’s own engineers that developed close
connection with key customers.
Sales and Marketing Ecosystem Partners
Medical Software Clinical Services
▪ Materialise provides customers with 3D printed surgical guides and
patient specific medical implants, allowing doctors to pre-operate in
models with the exact scenario they will face in the actual surgical
intervention.
▪ The procedure to develop a customized implant involves: 1) Sending
Materialise a CT scan; 2) Materialise’s clinical engineers to organise
a plan and design a proposal; 3) Doctors evaluating the proposal and
give feedback; 4) Materialise producing and shipping the personalised
implant, custom instruments and bone models to support the surgery.
▪ The 3D printed surgical guides include: shoulder, osteotomy, knee and
hip replacement surgeries, whilst the 3D printed implants are for
shoulder, hip and CMF implants.
▪ Materialise’s software allows medical-image based analysis,
engineering and 3D printed customized designs of surgical guides,
implants and other anatomical models.
▪ Materialise generates revenues in this sub-segment by selling
licenses to its medical software packages (eg. Materialise Mimics/
3-matic/ OrthoView/ ProPlan CMF) and software maintenance
contracts.
▪ Materialise Mimics is a medical software that allows 3D models to
be printed accurately from medical imaging-data eg. CT or MRI’s.
Currently, there are over 250 hospitals worldwide that use Materialise
Mimics Technology, especially in the Cardiac, Orthopedic, Vascular,
Neurological and Hepatobiliary areas.
Subsegments
“Offer products and services that address long-term trends in the medical industry towards personalized, functional and 
evidence -based medicine” - Materialise Investor Presentation
Strategy
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33%
Female
Company Overview | Management Team
Materialise’s Board of Directors transferred all management powers to the Executive Committee
Prior experience: engineering and consulting.
Founded Materialise in 1990 and since then has been recognized with
several awards as the most influential person in Additive Manufacturing
and one of the biggest contributors to the industry (RTAM/SME Industry





Product and Industry 
expertise: Vision, Technical 
Know-how, Passion.
Financial expertise: M&A 
knowledge, capital markets 
understanding, contract building & 
negotiation, philosophy and law.
Prior to being appointed director and Executive Chairman in 2013, Mr.
Leys was a Corporate Finance Partner at Baker & McKenzie CVBA. He
holds a Candidacy Degree in Philosophy from KU Leuven and Master of



















> 10 years seniority
KEY MEMBERS
Key Metrics







ARK Investment Mangement LLC
Nikko Asset Mangement Americas Inc.
Wilfried Vancraen & Hilde Ingelaere
Peter Leys
EMPLOYEES
The Executive Committee is 









Materialise employed 2,177 people in 
2019, growing the team by 8.4% YoY.
WomenExecutive 
members
The BoD is composed by 7 fully
independent members. There are 2




The above graph refers to the beneficial 
ownership of Materialise’s ordinary shares as of 
April 24th 2020.
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Education: 2 Masters - Bioengineering and Business Administration; Experience:
Cardiovascular clinical research and business analyst; Materialise: Joined in
1990, became a director in 1997 (managed HR, legal and finance departments)
and became Executive VP of MTLS Medical in 2011;
Education: Master in Mechanical Engineering and PhD in SLM Sintering;
Experience: Worked as a liaison engineer & set up research activities of a Co.
Materialise: Joined in 1995 and ran the 3D printing service bureau. Became
Executive VP in 2011 and CTO in 2016;
Education: Master in Electro-Mechanical Engineering w/ Stereolithography;
Materialise: Joined in 1990 and worked as a software sales manager, Director of
Sales and in 2011 became Exec. VP being responsible for global software;
Education: Master in Corporate Finance; Experience: CFO & member of the
Executive Committee (EC) & Director of a global laboratory (BARC NV); EC of
Cerba European Lab (acquirer of BARC); Materialise: Joined in 2015 in
representation of Alfinco BVBA;
Education: 2 Master - Mathematics and Applied Informatics; Experience: Software
architect and project manager of NXP Semiconductors; Materialise: Joined in
2010 for the cranio-maxillofacial business, in 2012 became the Director of the
Clinical Business Unit and in 2015 was VP & General Manager of MTLS Software;
Education: Master in Business Administration majoring in Engineering;
Experience: VP at Cordis Neurovascular and GM. Became CEO of Acertys group
(provider of medical devices and software); Materialise: Joined in 2016 in
representation of De Vet Management BVBA as a VP for the Medical segment;
Education: Master in Engineering; Materialise: Joined in 2001 as a project
manager, Rapid Tooling sales support and production management, International
Production Manager for the AM services and Sales Manager. Became VP of the
manufacturing segment; Source: Annual Reports; Materialise's Website
Market Overview
Political Economic Social Technological Legal Environmental
▪ 3DP requires political 
intervention as it could 
threaten people's 
security. Governments 
may need to control the 
dispersion of 3D 
printers by developing a 
database with all the 
locations and holders of 
3D printers.
▪ Government may need 
to intervene in order to 
prevent the production 
of illegal products that 
could lead to the 
creation of black 
markets.
▪ Finally, another issue 
that requires political 
intervention is the 3DP 
of designs that have 
intellectual property 
rights.
▪ Given the current 
economic outlook, 
subsidies and grants 
for research and 
development are likely 
to fall, which will surely 
impact the 3DP 
market.
▪ Likewise, taxation is 
expected to rise in the 
overall economy both 
direct and indirect.
▪ Finally, the private 
sector will also face 
great challenges 
accessing debt 
markets at reasonable 
conditions.
▪ 3DP allows companies 
to run their production 
in any part of the 
world. This will create 
pressure on the 
“traditional” 
manufacturing 
market as there is 




▪ The rising trend for the 
use of social 
networks may play a 
crucial role in the 
evolvement of 3DP. 
People will want to 
share their own 
customized 3D printed 
designs with friends, 
family and society as if 
they were sending 
photos or videos.
▪ 3DP is considered a 
disruptive technology 
in the manufacturing 
market, as it allows for 
the production and 
sharing of customised 
products and designs.
▪ However, the 3DP 
market has not yet 
reached its peak or 
maturity, as new 
technologies arise 
allowing people to 
model even more their 
designs and use 
different materials.
▪ The 3DP market highly 
relies on intellectual 
property (IP).
Manufacturers and 
software designers are 
protected by patents for 
a limited number of 
years. However, with 
the growth of the 3DP 
market new legislation 
will be required.
▪ As it was mentioned in 
the political factors, the 
breach of IP rights and 
contraband production 
are issues that put 
constrains on the 
development of the 
3DP market and that 
call for heavy 
legislation.
▪ When it comes to 
mineral resource 
consumption and 
water waste, 3DP is 
considered more 




▪ On the other hand, 
researchers claim that 
the 3DP process has 
high energy demands, 
which can contribute to 
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Income Statement (in €m) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19
 Software 11 13 18 26 30 36 37 42
 Medical 25 28 30 35 38 43 52 61
 Manufacturing 23 27 33 41 46 64 95 94
Total Revenue 59 69 81 102 114 142 185 197
Growth % - 17% 18% 25% 12% 24% 30% 7%
Gross Profit 35 42 49 59 68 80 102 110
Gross Margin % 60% 60% 60% 58% 59% 56% 55% 56%
 Research and development expenses (9) (11) (15) (18) (18) (20) (22) (23)
 Sales and marketing expenses (20) (22) (28) (37) (36) (39) (46) (53)
 General and administrative expenses (8) (9) (12) (15) (20) (25) (32) (32)
EBITDA (unaudited) 5 8 5 3 8 13 22 26
Adjustments to EBITDA 0 0 1 1 1 2 1 0
Normalized EBITDA (unaudited) 5 8 6 4 9 15 24 27
EBITDA margin % 9% 11% 7% 4% 8% 10% 13% 14%
Net profit 1 3 2 (3) (3) (2) 3 2
Profit Margin % 2% 5% 2% -3% -3% -1% 2% 1%
IPO
Historical Financials | Income Statement






FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19
Net Sales Breakdown by Segment












The Medical Segment revenue growth from FY17-18
was entirely due to an increase in partner sales,
especially in the business lines of CMF, shoulder and
knee devices. From FY18-19, the acquisition of
Engimplan contributed with €2.4m additional
revenue and while observing continued growth from
partner business sales (especially CMF).
The acquisition of ACTech resulted in €43.4m
additional revenue from the sale of printed industrial
and consumer products, causing the manufacturing
segment to weigh 51.4% of revenues compared to
44.7% in FY17.
The stagnation of growth in manufacturing revenues
due to a less favorable economic scenario in FY19
(i.e. trade war) broke the revenue trend, although
partially offset by increases in other segments.
Increase in costs mainly reflect the acquisition of
ACTech. Increasing operation costs mainly driven by
S&M and G&A expenses, both largely composed by
payroll expenses.
Materialise reaches profitability after increases in
revenues from ACTech more than offset increase in
costs.




10% 20% 18%4% 8%











Revenues & EBITDA margin
Software Medical Manufacturing
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Historical Financials | BS & CFS










FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19
CFO CFO/Revenues
Balance Sheet  (in €m) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19
Cash and Cash Equivalents 6 13 51 51 56 43 116 129 
NWC w/ Cash 4 7 53 46 48 35 96 107 
Equity 13 18 85 83 79 77 136 143 
Net Debt 9 4 (34) (30) (22) 51 (9) (11)
Net Debt/EBITDA 2x 0x -6x -8x -2x 4x 0x 0x
ROE 11% 19% 2% -3% -4% -3% 2% 1%
ROA 3% 6% 1% -2% -2% -1% 1% 0%
Cash Flow Statement  (in €m) FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19
Normalized EBITDA 5 8 6 4 9 15 24 27 
Income tax paid 0 0 (0) (0) (1) (2) (1) (2)
CFO 6 9 5 2 8 10 28 28 
Purchase of PPE (4) (2) (10) (9) (12) (28) (18) (13)
Acquisition of Subsidiary (net of cash) 0 (0) (10) (2) 0 (27) 0 (6)
CFI (5) (3) (31) (3) (13) (59) (22) (26)
Net Proceeds of Loans & Borrowings 3 1 (1) 1 12 42 14 17 
Capital Increase in Parent Company (1) 0 70 1 0 0 60 1 
CFF 2 1 62 (2) 9 38 65 11 
CFO/Revenues 10% 13% 6% 2% 7% 7% 15% 14%
CFO/Assets 13% 16% 4% 2% 5% 4% 9% 8%









FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19













In June 2014, Materialise went public and sold around 8
million ADS's at a price of $12.00 per ADS. According to
Materialise’s financial reports, the company received
net proceeds from the IPO of approximately $88.3M.
In July 2018, MTLS closed a private placement of
around 2M ordinary shares to BASF Antwerpen. One
week later the company performed a secondary
public offering of over 3M ADSs at a price of $13.00
per ADS. Collectively, these capital increases rendered
approximately $65.2M in net proceeds for MTLS.
Usually in possession of more cash & eq. relative to its
financial obligations, we can see a temporary switch in
2017 given a major increase in Loans & Borrowings to
fund ACTech (€27.2M) and PPE (€27.7M).
In 2014, MTLS acquired OrthoView, an Orthopedic
Pre-Operative Planning Software Co. In 2017, acquired
ACTech, full-service manufacturer of complex metal
parts. On August 2019, Materialise concluded the
acquisition of Engimplan, a Brazilian company
specialized in manufacturing of orthopaedic and CMF
implants and instruments.
This increase in Loans & Borrowings reflect the
financing of ACTech’s acquisition, expansion of PPE
and R&D projects.
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CAPEX (in €M) FY15 FY16 FY17 FY18 FY19
Purchase of PPE (9) (12) (28) (18) (13)
Proceeds from of PPE & intangibles 0 2 0 0 0
Purchase of intangible assets (2) (2) (4) (2) (2)
Acquisition of subsidiary (net of cash) (2) 0 (27) 0 (6)
CAPEX (12) (13) (59) (20) (22)
Maintenance (7) (8) (13) (17) (15)
Expansion (5) (4) (46) (3) (6)
Free Cash Flow (in €M) FY15 FY16 FY17 FY18 FY19
EBITDA 4 9 15 24 27
Depreciation & Amortization (7) (8) (13) (17) (19)
EBIT (3) 1 2 6 7
Operating Taxes 0 (2) (1) (0) (3)
Maintenance CAPEX (7) (8) (13) (17) (15)
Expansion CAPEX (5) (4) (46) (3) (6)
Change in NWC 1 2 (7) 10 3
FCF (6) (3) (52) 13 5
Historical Financials | FCF
Materialise’s strategic acquisition of ACTech in 2017 had a great impact on historic FCF’s







1 EBITDA experienced a constant growth since
2015 with a CAGR of 73%. The rise in EBITDA
is mainly explained by the EBITDA Margin
improvement and a smaller part driven by
revenue growth.
The FCFs have been unstable mainly due to
the CAPEX, which includes acquisitions of
subsidiaries. However, since 2018 the cash
flows have been increasing driven by the
EBITDA growth.
In 2017 Materialise acquired ACTech, a German
full-service manufacturer of complex metal parts, for
a total of €28M in cash. This acquisition led to a
drastic change in the expansion CAPEX and
consequently a very negative FCF in 2017 of around
€52M.
The Net Working Capital has been changing steadily
over the period of 2015 to 2019. These changes are
mainly explained by the acquisitions and strategic
partnerships that Materialise established over the
past few years. Not only ACTech in 2017 but also
Engimplan in 2019.
















FY15 FY16 FY17 FY18 FY19
In €M
EBITDA FCF EBITDA Margin
Sources: Annual Report, Investor Relations
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Business Model | Overall Business Plan
Both scenarios show potential Top and Bottom-line improvements
Top Line Bottom Line Investments
1
2
Increasing focus in the APAC and US regions by
engaging in strategic partnerships. Special focus in
Workflow & CAD Software, in order to enable
customized mass-production. Expand the offer of
metal-based printing, key growth area with increasing
demand in the AM industry. In terms of revenues, the
period 2020-2027 has a CAGR of 17.3%.
This growth can be explained by the revenue synergies
arising from the vertical and horizontal integration of
Stratasys into Materialise’s business. Post-acquisition
the company becomes an all-in-one supplier which
allows for the target of a larger customer base. In
terms of revenues, the period 2020-2027 has a CAGR
of 16.7%.
1
Materialise already possesses a strong GM when
compared to its top competitors. In 2019 Materialise’s
GM was 61% while Stratasys had a GM of 49%. Post-
acquisition, Materialise’s operational efficiency will
contribute to the improvement of Stratasys margins. In
addition, the company will also benefit from a higher
bargaining power with suppliers.
2
In the Stand-Alone scenario Materialise is expected to
be able to improve its EBITDA margin at a CAGR of
5.2% between 2020 and 2027. With the acquisition of
Stratasys, the company will benefit from R&D and
SG&A synergies, mainly in the Service Provider
segment. This will result in a CAGR of around 6.4% of
the EBITDA margin between 2020 and 2027.
1
In 2019, Materialise’s NWC was -4% of revenues,
meaning a quick generation of cash from operations,
while Stratasys had 32%. Post-acquisition, the
company will hold a stronger bargaining power with its
customers and suppliers. In the acquisition scenario,
from 2020 to 2022 the NWC will fall steadily, until it
remains constant at around 1% from 2022-onwards.
2
In the stand-alone scenario CAPEX will slightly
decrease from 8% to 3% of sales until 2027. In the
acquisition scenario, the CAPEX will require larger
investments in order to streamline operations across
countries. On the other hand, there will also be
divestures in the geographical areas where both
companies are present.





Net Working Capital (NWC)
CAPEX









2020 2021 2022 2023 2024 2025 2026 2027












2020 2021 2022 2023 2024 2025 2026 2027
NWC (% of sales) Stand-Alone Acquisition
Individual Paper
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Exit & Returns | Sources and Uses - Acquisition Scenario
A leverage of 12.0x EBITDA is the optimal level that will maximize Materialise’s returns 
Capital Structure Debt Financing
Equity FinancingDebt Repayment Schedule (in €M)
1 Fixed Return Instrument (18.0x EBITDA)
Guaranteed rate of return (PIK) of 3%;
Management buy-in of €10M, 2.0% of FRIs;
2 Ordinary Equity (0.9x EBITDA)
The Management contributed sweet equity 
of €5M, 2x their yearly wage. In addition, 
contributed with €0.4M through Inst. Ords, 
around 1.6% of Ordinary Equity.
1 Term Loan A (2.0x EBITDA)
Secured debt; 7-year amortized loan; Interest rate of 2.0% + 3M Euribor;
2 Term Loan B (5.0x EBITDA)
Secured debt; 7-year bullet loan; Interest rate of 5.5% + 3M Euribor;
3
Mezzanine Debt (5.0x EBITDA)
Unsecured debt; 7-year bullet loan; Interest rate divided in PIK Element of 
6.0% and Cash Element of 1.0% + 3M Euribor;
The total debt financing represents around €321M (39%), corresponding to a multiple
of 12.0x EBITDA. The debt sources are divided in Senior debt and Subordinated
debt, where Senior debt is divided in two tranches, Term Loan’s A and B:
The total equity financing represents around €506M (61%), corresponding to a
multiple of 18.9x EBITDA.
Sources of Funds  € x EBITDA %  € x EBITDA
Senior debt 27
Term Loan A 54 2,0x 6% 25,1x
Term Loan B 134 5,0x 16% 671
129
Subordinated debt 2
Mezzanine 134 5,0x 16% 125
665 26,5x
Total debt 321 12,0x 39% Refinancing of Debt 129 4,8x
Fees 5% 34 1,3x
Fixed Return Instrument 481 18,0x 58%
Ordinary Equity 25 0,9x 3%
Institutional Investor 20
Sweet Equity 5 20%
Total Equity 506 18,9x 61%









Breakdown of Equity € %
Institutional Strip 501
Fund 491
Fixed Return Instrument 472
Institutional Ords 19 78%
Management 10
Fixed Return Instrument 10
Institutional Ords 0 2%
Sweet Equity 5 20%
Total Equity 506 100%
134 134 134 134 134 134 134
0
134 138 146 155
164 174 184
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Exit & Returns | Sources and Uses - Standalone Scenario
A leverage of 14.0x EBITDA is the optimal level that will maximize Materialise’s returns 
Capital Structure Debt Financing
Equity FinancingDebt Repayment Schedule (in €M)
1 Fixed Return Instrument (16.0x EBITDA)
Guaranteed rate of return (PIK) of 3%;
Management buy-in of €10M, 2.2% of FRIs;
2 Ordinary Equity (0.9x EBITDA)
The Management contributed sweet equity 
of €5M, 2x their yearly wage. In addition, 
contributed with €0.4M through Inst. Ords, 
around 1.8% of Ordinary Equity.
1 Term Loan A (2.0x EBITDA)
Secured debt; 8-year amortized loan; Interest rate of 2.0% + 3M Euribor;
2 Term Loan B (6.0x EBITDA)
Secured debt; 8-year bullet loan; Interest rate of 5.5% + 3M Euribor;
3
Mezzanine Debt (6.0x EBITDA)
Unsecured debt; 8-year bullet loan; Interest rate divided in PIK Element of 
6.0% and Cash Element of 1.0% + 3M Euribor;
The total debt financing represents around €375M (45%), corresponding to a multiple
of 14.0x EBITDA. The leverage is higher in this scenario as there isn´t the additional
risk of integrating a large manufacturer, Stratasys, into Materialise's business. The
debt sources are divided in Senior debt and Subordinated debt, where Senior debt is
divided in two tranches, Term Loan’s A and B:
The total equity financing represents around €453M (55%), corresponding to a
multiple of 16.9x EBITDA.
Sources of Funds  € x EBITDA %  € x EBITDA
Senior debt 27
Term Loan A 54 2,0x 6% 25,1x
Term Loan B 161 6,0x 19% 671
129
Subordinated debt 2
Mezzanine 161 6,0x 19% 125
665 26,5x
Total debt 375 14,0x 45% 129 4,8x
Fees 4% 34 1,3x
Fixed Return Instrument 428 16,0x 52%
Ordinary Equity 25 0,9x 3%
Institutional Investor 20
Sweet Equity 5 20%
Total Equity 453 16,9x 55%










Breakdown of Equity € %
Institutional Strip 448
Fund 438
Fixed Return Instrument 418
Institutional Ords 19,4 78%
Management 10
Fixed Return Instrument 9
Institutional Ords 0 2%
Sweet Equity 5 20%
Total Equity 453 100%
161 161 161 161 161 161 161 161
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Exit and Returns | Entry Valuation for EV
Valuation analysis suggest a COVID-adjusted EV of €1.1bn at a multiple of 43.5x for Materialise
Methodology
0 500 1,000 1,500 2,000











41.5x (23.3x - 153.9x)
43.2x (16.6x – 50.9x)
25.1x (16.7x – 63.5x)
26.5x (13.9x – 43.4x)
43.5x (29.2x – 48.2x)
20.9x (14.2x – 24.0x)
27.5x (16.7x – 31.0x)
12.1x (9.7x – 16.6x)
14.1x (8.3x – 19.1x)
25.1x - €670m
With very few public comparables available in the AM
market, other software and hardware manufacturers with
similar business models were analysed and selected for
valuation purposes.
Past Transactions were taken from an EY report2 covering
M&A activity in the AM industry for the past 5 years.
Data was collected for a 5-year period, ranging from 2014
to 2019. Discrepancies across valuation metrics can be due
to missing or invalid values such as negative earnings, which
are common in high-growth industries.
Since methodologies weren’t COVID-adjusted, our chosen
valuation multiples were the best proxy for each company’s
value in mid 2020, when the acquisitions would take place.
Software companies trade at relatively higher multiple values
than hardware manufacturers, hence the differences
between entry multiples for Materialise and Stratasys
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Exit & Returns | Key Credit Statistics & Model Returns – Acquisition Scenario
The Acquisition scenario achieves an overall MM of 8.4x, translating into a €3.80bn of value creation
Institutional & Management Returns – IC
Cash generation stood strong and improving above
1.0x during the investment period. The reduction






The exit planned in 2026 is set to happen at a valuation of €3.92bn. The
upside is captured by the Institutional Ords and Sweet Equity while Net
Debt decreases to negative figures, with larger discrepancies in more
optimistic models. Additionally, FRI remains constant.
The fund is expected to provide a MM return of 7.2x, yielding top management a 62.7x
return and achieving an IRR of 35%.
Net Debt to EBITDA ratio substantially improves to
0.0x at exit, with the strengthening of EBITDA
margins, as the company is able to generate
higher cash levels while also repaying its debt.
Despite only 17% of total debt being amortized, the
ratio became steeper as EBITDA rose
exponentially until standing at 31.9x in the exit
year.












1.9x 1.1x 0.5x 0.0x
1.2x
2020E 2021E 2022E 2023E 2024E 2025E 2026E 2027E












Exit Options & Due DiligenceExit & ReturnsValue Creation & Business PlanCompany & Market Overview
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0
Entry EV
Exit EV - BC
Exit EV - IC
Exit EV - MC
Exit Enterprise Value Evolution
Sweet Equity Institutional Ords FRI Net Debt
Exit & Returns | Key Credit Statistics & Model Returns – Standalone Scenario





Institutional & Management Returns – IC
Credit Statistics – BC
Credit Statistics
The exit planned in 2027 is set to happen at a valuation of €3.05bn. The
upside is captured by the Institutional Ords and Sweet Equity while
Net Debt decreases, with larger discrepancies in more optimistic models.
Additionally, FRI remains constant.
The fund is expected to provide a MM return of 5.1x yielding top management a 36,1x
return and achieving an IRR of 24%.
Cash generation stood strong above 1.0x and
constantly improving during the investment
period. The reduction of this ratio to 0.2x relates to
the repayments done in 2027.
Net Debt to EBITDA ratio is reducing over time,
improving to 1.0x at exit, with the strengthening of
EBITDA margins and the higher cash generation,
despite debt levels still increasing.
Despite the inexistence of amortizable debt, the
ratio became steeper as EBITDA rose
exponentially until standing at 10.9x in the exit
year.
Nova School of Business and Economics | Private Equity Challenge Thesis | Materialise | 2020/21 22
12.9x
6.6x 5.5x 4.1x 3.3x 2.5x 1.7x 1.0x
2020E 2021E 2022E 2023E 2024E 2025E 2026E 2027E










1.4x 1.5x 1.4x 1.8x
2.6x
3.6x 0.2x
2020E 2021E 2022E 2023E 2024E 2025E 2026E 2027E
Cash Cover
IC BC
Exit Options & Due DiligenceExit & ReturnsValue Creation & Business PlanCompany & Market Overview
Exit & Returns | Value Creation – Acquisition Scenario 








FRI Inst Ords Sweet Equity
Exit Waterfall (€M)
Value Creation Breakdown (€M)
▪ At exit, the Enterprise Value will be €3.9bn. With no debt outstanding and excess
cash of €0.4bn, the Equity value is expected to grow from €0.5bn to €4.3bn,
implying a value creation of nearly €3.8bn until 2026.
▪ During the holding period, Materialise operations will be able to generate more than
enough cash (€0.5bn) to repay all the outstanding debt. Thus, the total Net Debt will
go from €0.2bn to -€0.3bn.
▪ After deducting the sub loan (FRI), shareholders remain with a total of €3.7bn
(Ordinary Shares), with €0.7bn corresponding to sweet equity (20%) and €3bn to
institutional investors (80%).
Comments
▪ Revenue growth is the major source of value creation, due to both organic and
inorganic growth, contributing with roughly €5bn – being €0.6bn provided by
Stratasys acquisition and €4.4bn by the Additive Manufacturing’s market growth
and merger synergies.
▪ Improvements in EBITDA margin are expected to represent a value creation of
€4.5bn (+9.4pp) driven by our business plan to improve the company’s operating
efficiency, aiming at a margin in line with larger competitors in the industry to which
Materialise will compare after the vertical integration.
▪ The exit EV/EBITDA multiple (9.7x) is expected to decrease significantly over time
in the acquisition scenario. The difference is explained by the current expectations in
the 3D printing market that are foreseen to cool down after a very bullish period. In
addition, Stratasys has a lower multiple what contributes to a negative multiple
arbitrage. For the multiples estimation, it was assumed the median of the
EV/EBITDA Cycle.
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Exit & Returns | Value Creation – Standalone Scenario
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▪ At exit, the Enterprise Value will be €3bn, being 98% attributable to Equity,
implying a value creation of nearly €2.5bn.
▪ The total Net Debt will go from €196M to €61M, representing roughly 2% of the EV
at the exit. This debt repayment is possible with the cash generation from the
operating activity of approximately €135M.
▪ After deducting the sub loan (FRI), shareholders remain with a total of €2.5bn of
ordinary shares, where €0.5bn corresponds to sweet equity (20%) and €2bn to
institutional investors (80%).
Comments
▪ Improvement in the EBITDA margin from 13.6% to 24.5% is the major source
of value creation (€1.2bn), driven by reductions in operating and non-operating
costs, as we shrink the cost margins by leveraging on scale.
▪ Revenue growth will contribute with nearly €1.1bn to value creation driven by the
Additive Manufacturing market’s massive growth.
▪ The exit EV/EBITDA multiple (25.1x) is the same as the entry multiple. Kindly note
that the exit multiple is still higher than in the acquisition scenario since in the
previous case it is added a company (Stratasys) with a lower multiple than
Materialise which also decreases substantially in 2027. For the multiples estimation,
it was assumed the median of the EV/EBITDA Cycle.
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Exit Waterfall (€M)
Value Creation Breakdown (€M)
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Exit & Returns | Sensitivity Analysis
Even if the vertical integration strategy isn’t feasible, other value creation plans secure strong upside
Acquisition Scenario Standalone Scenario
▪ Returns remain attractive across both scenarios, although the acquisition of Stratasys would provide significantly higher upside.
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∫
See appendix 12 for more sensitivity analyses
Exit Options & Due DiligenceExit & ReturnsValue Creation & Business PlanCompany & Market Overview
• The most recent bankrupcies during this crisis have highlighted and brought to discussion lack of regulation in the form of financing LBOs. In 2013, the Federal Reserve 
issued guidelines on LBO financing related to maximum leverage and it is now debated whether such limits should become mandatory.
• As established above, private equity activity is highly exposed to systematic risk and the conditions of capital markets. Through the uncertainty of the following years 
regarding the evolution of the pandemic and the economic recovery, the number of LBOs is expected to fall considerably.
• On the other hand, after the pandemic and with more stable market conditions, most private equity firms will find out many investment opportunities with companies 
facing restructuring needs and at a discount price. 
Leverage Buyouts after the pandemic
LBO’s trend in recent years and COVID impact in the future
• In the United States, Private Equity funds raised more than $500 billion in 2019 
being $393 billion correspondent to LBO deals. The average buyout deal size
LBO Trends before 2020
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COVID impact in Leverage Buyouts
• LBO companies usually carry high levels of risk due to large amounts of Debt. In 
times of economic crisis, whether it’s a traditional recession or a pandemic, the 
more difficulty companies will have to generate cashflows from the operating 
activities and the higher the probability of default.
• The pandemic has caused an increase in bankruptcies for a wide range of 
companies, some of which belong to private equity firms.
• For this reason, Materialise could not ask for high levels of debt, taking into 




reached the highest in the decade ($419
million)
• The LBO model can work well during 
booms. In the most recent years, with 
interest rates with historically low levels 
and with hedge funds underperforming the 
market, Private Equity companies end up 
2019 with a record value of $1.43 trillion of 
capital available.
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